NASDAQ: BWAY
Brainsway Ltd Stock

$12.31-0.33 (-2.61%)
Updated Jul 11, 2025
BWAY Price
$12.31
Fair Value Price
N/A
Market Cap
$231.59M
52 Week Low
$5.98
52 Week High
$13.63
P/E
51.29x
P/B
3.63x
P/S
4.1x
PEG
2.34x
Dividend Yield
N/A
Revenue
$43.46M
Earnings
$3.92M
Gross Margin
74.5%
Operating Margin
14.12%
Profit Margin
9%
Debt to Equity
0.57
Operating Cash Flow
$12M
Beta
0.84
Next Earnings
Aug 6, 2025
Ex-Dividend
N/A
Next Dividend
N/A

BWAY Overview

Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine BWAY's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More

Zen Rating Component Grades

B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Device

Industry Rating
C
BWAY
Ranked
#20 of 104

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$11.93A
$228.03A
$30.28A
View Top Medical Device Stocks

Be the first to know about important BWAY news, forecast changes, insider trades & much more!

BWAY News

Overview

Due Diligence Score

Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how BWAY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BWAY ($12.31) is trading above its intrinsic value of $3.19, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BWAY is poor value based on its earnings relative to its share price (51.29x), compared to the US market average (30.99x)
P/E vs Market Valuation
BWAY is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more BWAY due diligence checks available for Premium users.

Valuation

BWAY fair value

Fair Value of BWAY stock based on Discounted Cash Flow (DCF)

Price
$12.31
Fair Value
-$5.97
Undervalued by
306.27%
BWAY ($12.31) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

BWAY price to earnings (PE)

For valuing profitable companies with steady earnings

Company
51.29x
Industry
35.68x
Market
30.99x
BWAY is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
BWAY is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

BWAY price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
3.63x
Industry
4.06x
BWAY is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

BWAY price to earnings growth (PEG)

For valuing profitable companies with growth potential

BWAY is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

BWAY's financial health

Profit margin

Revenue
$11.5M
Net Income
$1.1M
Profit Margin
9.6%
BWAY's Earnings (EBIT) of $6.14M... subscribe to Premium to read more.
Interest Coverage Financials
BWAY's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$100.2M
Liabilities
$36.4M
Debt to equity
0.57
BWAY's short-term assets ($84.66M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BWAY's short-term assets ($84.66M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BWAY's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
BWAY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$5.0M
Investing
-$2.0M
Financing
-$755.0k
BWAY's operating cash flow ($12.13M)... subscribe to Premium to read more.
Debt Coverage Financials

BWAY vs Medical Device Stocks

TickerZen RatingMarket Cap1d %P/EP/B
BWAYB$231.59M-2.57%51.29x3.63x
TCMDC$231.55M-2.92%14.87x1.13x
QTRXD$228.71M+0.60%-4.75x0.72x
MXCTC$236.03M-2.63%-5.55x1.18x
MASSC$248.88M-3.88%-12.85x1.56x

Brainsway Stock FAQ

What is Brainsway's quote symbol?

(NASDAQ: BWAY) Brainsway trades on the NASDAQ under the ticker symbol BWAY. Brainsway stock quotes can also be displayed as NASDAQ: BWAY.

If you're new to stock investing, here's how to buy Brainsway stock.

What is the 52 week high and low for Brainsway (NASDAQ: BWAY)?

(NASDAQ: BWAY) Brainsway's 52-week high was $13.63, and its 52-week low was $5.98. It is currently -9.68% from its 52-week high and 105.85% from its 52-week low.

How much is Brainsway stock worth today?

(NASDAQ: BWAY) Brainsway currently has 37,626,427 outstanding shares. With Brainsway stock trading at $12.31 per share, the total value of Brainsway stock (market capitalization) is $231.59M.

Brainsway stock was originally listed at a price of $11.09 in Apr 17, 2019. If you had invested in Brainsway stock at $11.09, your return over the last 6 years would have been 11%, for an annualized return of 1.75% (not including any dividends or dividend reinvestments).

How much is Brainsway's stock price per share?

(NASDAQ: BWAY) Brainsway stock price per share is $12.31 today (as of Jul 11, 2025).

What is Brainsway's Market Cap?

(NASDAQ: BWAY) Brainsway's market cap is $231.59M, as of Jul 12, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Brainsway's market cap is calculated by multiplying BWAY's current stock price of $12.31 by BWAY's total outstanding shares of 37,626,427.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.